Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Malluche

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
Clinical Nephrology|June 5, 2003
Parathyroid hormone assays--evolution and revolutions in the care of dialysis patientsH H Malluche, H Mawad, D Trueba, et al.
Bone|May 1, 1993
Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeysD S Metsger, I Arnala, M C Faugere, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 25, 2016
Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonatesJ Ward, C Wood, K Rouch, et al.
The Journal of Pediatrics|December 1, 1990
More on aluminum toxic effects in children with uremiaM Freundlich, G Zilleruelo, J Strauss, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1986
Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysisM C Faugere, I O Arnala, E Ritz, et al.
Calcified Tissue Research|August 1, 1976
Intestinal calcium absorption and whole-body calcium retention in various stages of renal insufficiencyE Werner, H H Malluche, J Kutschera, et al.
Clinical Nephrology|August 12, 2000
Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failureZ Geng, M C Monier-Faugere, F Bauss, et al.
Clinical Nephrology|September 28, 1999
Calcific uremic arteriolopathy in association with low turnover uremic bone diseaseH W Mawad, B P Sawaya, R Sarin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1995
Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysisQ Qi, M C Monier-Faugere, Z Geng, et al.
The New England Journal of Medicine|July 19, 1984
The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failureH H Malluche, A J Smith, K Abreo, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Clinical Nephrology|June 5, 2003
Parathyroid hormone assays--evolution and revolutions in the care of dialysis patientsH H Malluche, H Mawad, D Trueba, et al.
Bone|May 1, 1993
Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeysD S Metsger, I Arnala, M C Faugere, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 25, 2016
Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonatesJ Ward, C Wood, K Rouch, et al.
The Journal of Pediatrics|December 1, 1990
More on aluminum toxic effects in children with uremiaM Freundlich, G Zilleruelo, J Strauss, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1986
Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysisM C Faugere, I O Arnala, E Ritz, et al.
Calcified Tissue Research|August 1, 1976
Intestinal calcium absorption and whole-body calcium retention in various stages of renal insufficiencyE Werner, H H Malluche, J Kutschera, et al.
Clinical Nephrology|August 12, 2000
Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failureZ Geng, M C Monier-Faugere, F Bauss, et al.
Clinical Nephrology|September 28, 1999
Calcific uremic arteriolopathy in association with low turnover uremic bone diseaseH W Mawad, B P Sawaya, R Sarin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1995
Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysisQ Qi, M C Monier-Faugere, Z Geng, et al.
The New England Journal of Medicine|July 19, 1984
The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failureH H Malluche, A J Smith, K Abreo, et al.
Pageof 22